![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:7260G Cambridge Antibody Tech Group PLC 22 December 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Cambridge Antibody Technology Group plc 2) Name of shareholder having a major interest OrbiMed Advisors LLC 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them OrbiMed Advisors LLC 5) Number of shares/amount of stock acquired Nil 6) Percentage of issued class Nil 7) Number of shares/amount of stock disposed 537,000 Ordinary Shares and 113,000 American Depositary Receipts 8) Percentage of issued class 1.263% 9) Class of security Ordinary 10 pence shares 10) Date of transaction 20 December 2004 11) Date company informed 21 December 2004 12) Total holding following this notification 2,768,000 of which 2,417,000 are held in the form of ordinary 10 pence shares and 351,000 are held in the form of American Depositary Receipts 13) Total percentage holding of issued class following this notification 5.38% 14) Any additional information OrbiMed Advisors LLC has investment management discretion over the following securities: Caduceus Capital Master Fund Limited Caduceus Capital II L.P. UBS Eucalyptus Fund L.L.C. UBS Eucalyptus Fund Ltd HFR SHC Aggressive Master Trust Knightsbridge Post Venture IV L.P. Knightsbridge Integrated Holdings, V, L.P. Knightsbridge Netherlands II L.P. Knightsbridge Integrated Holdings IV Post Venture LP Knightsbridge Post Venture III LP Knightsbridge Netherland I LP Knightsbridge Netherlands III LP Knightsbridge Integrated Holdings II Limited Knightsbridge Venture Capital VI LP Knightsbridge Venture Capital IV L.P. Knightsbridge Venture Capital III LP Topanga XIII Inc. Caduceus Capital III, L.P. 15) Name of contact and telephone number for queries Justin Hoskins 01223 898589 16) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of notification: 22 December 2004 This information is provided by RNS The company news service from the London Stock Exchange END HOLEAFAAAEALFFE
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions